Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Linolenic Acid: A Closer Look at Its Synthesis, Composition, and Regulatory Aspects
Linolenic acid, is a crucial polyunsaturated omega-3 fatty acid that plays an integral role in human physiology and nutrition.
Dec 12,2024 APISynthesis and toxicity of m-Cresol
m-Cresol is one of the isomeric compounds of methylphenol, including o-cresol and p-cresol. m-Cresol can be used as a chemical intermediate and is widely used in the fields of medicine and pesticides.
Dec 12,2024 APIWhat are the connections between naphthalene, 1-naphthol (1-NAP) and 2-naphthol (2-NAP) and how to detect 1-NAP and 2-NA
Naphthalene (NAP), 1-naphthol (1-NAP) and 2-naphthol (2-NAP) are bicyclic hydrocarbons (Figure 1) used in the production of dyes, synthetic rubber, pesticides and pharmaceutical industries.
Dec 11,2024 APISide effects of Nickel sulfate
Nickel sulfate (Nickel(II) sulfate, NiSO4) is a yellow, green, or blue crystalline inorganic compound that produces toxic gases when heated.
Dec 11,2024 APIWhat are the uses of 1,3-Dimethoxybenzene?
1,3-Dimethoxybenzene (1,3-DMB) is a volatile aromatic compound found in port wine and is commonly used as a solvent, flavoring and fragrance.
Dec 11,2024 APIIs 1,2-Dimethoxyethane a polar or non-polar compound?
1,2-Dimethoxyethane (DME) is a non-polar compound with a relative polarity of 0.231 and is slightly soluble in water.
Dec 11,2024 APIWhat does oleanolic acid used for? Is it safe?
oleanolic acid is a highly potent compound which shows variety of biological activities. It is known for their antimicrobial, hepatoprotective, anti-inflammatory, antiallergic, antiviral and cytotoxic
Dec 11,2024 APILithium Tetrafluoroborate: Applications in the Development of Lithium Batteries and its Toxicity
Lithium tetrafluoroborate (LiBF4) is widely used as an electrolyte for primary and secondary batteries.
Dec 10,2024 APICandesartan cilexetil: Pharmacodynamics, Pharmacokinetics and Therapeutic Uses
Candesartan cilexetil, an angiotensin II receptor antagonist, effectively reduces blood pressure and benefits patients with hypertension, renal failure, and type 2 diabetes mellitus.
Dec 10,2024 APIThe Comprehensive Guide to Rituximab: Mechanisms, Applications, and Care
Rituximab, a pioneering chimeric monoclonal antibody, has been a beacon of hope in the realms of oncology and immunology.
Dec 10,2024 API












